Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, Zippelius A, Mayer F, Reck M, Atanackovic D, Thomas M, Schneller F, Stöhlmacher J, Bernhard H, Gröschel A, Lander T, Probst J, Strack T, Wiegand V, Gnad-Vogt U, Kallen KJ, Hoerr I, von der Muelbe F, Fotin-Mleczek M, Knuth A, Koch SD.

Cancer Immunol Immunother. 2019 May;68(5):799-812. doi: 10.1007/s00262-019-02315-x. Epub 2019 Feb 15.

PMID:
30770959
2.

β6 -integrin serves as a novel serum tumor marker for colorectal carcinoma.

Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M.

Int J Cancer. 2019 Aug 1;145(3):678-685. doi: 10.1002/ijc.32137. Epub 2019 Jan 29.

PMID:
30653264
3.

Human Cardiac Organoids for Disease Modeling.

Nugraha B, Buono MF, von Boehmer L, Hoerstrup SP, Emmert MY.

Clin Pharmacol Ther. 2019 Jan;105(1):79-85. doi: 10.1002/cpt.1286. Epub 2018 Dec 21. Review.

PMID:
30415499
4.

Cardiovascular tissue engineering: From basic science to clinical application.

Fioretta ES, von Boehmer L, Motta SE, Lintas V, Hoerstrup SP, Emmert MY.

Exp Gerontol. 2019 Mar;117:1-12. doi: 10.1016/j.exger.2018.03.022. Epub 2018 Mar 28. Review.

PMID:
29604404
5.

Sequencing and cloning of antigen-specific antibodies from mouse memory B cells.

von Boehmer L, Liu C, Ackerman S, Gitlin AD, Wang Q, Gazumyan A, Nussenzweig MC.

Nat Protoc. 2016 Oct;11(10):1908-1923. doi: 10.1038/nprot.2016.102. Epub 2016 Sep 15.

PMID:
27658009
6.

Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site.

Gristick HB, von Boehmer L, West AP Jr, Schamber M, Gazumyan A, Golijanin J, Seaman MS, Fätkenheuer G, Klein F, Nussenzweig MC, Bjorkman PJ.

Nat Struct Mol Biol. 2016 Oct;23(10):906-915. doi: 10.1038/nsmb.3291. Epub 2016 Sep 12.

7.

Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory.

Gitlin AD, von Boehmer L, Gazumyan A, Shulman Z, Oliveira TY, Nussenzweig MC.

Immunity. 2016 Apr 19;44(4):769-81. doi: 10.1016/j.immuni.2016.01.011. Epub 2016 Mar 2.

8.

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers.

Gross S, Lennerz V, Gallerani E, Mach N, Böhm S, Hess D, von Boehmer L, Knuth A, Ochsenbein A, Gnad-Vogt U, Forssmann U, Woelfel T, Kaempgen E.

Cancer Immunol Res. 2016 Jan;4(1):18-25. doi: 10.1158/2326-6066.CIR-15-0105. Epub 2015 Nov 12.

9.

Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice.

Dosenovic P, von Boehmer L, Escolano A, Jardine J, Freund NT, Gitlin AD, McGuire AT, Kulp DW, Oliveira T, Scharf L, Pietzsch J, Gray MD, Cupo A, van Gils MJ, Yao KH, Liu C, Gazumyan A, Seaman MS, Björkman PJ, Sanders RW, Moore JP, Stamatatos L, Schief WR, Nussenzweig MC.

Cell. 2015 Jun 18;161(7):1505-15. doi: 10.1016/j.cell.2015.06.003.

10.

Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma.

Dannenmann SR, Hermanns T, Bransi A, Matter C, von Boehmer L, Stevanovic S, Schraml P, Moch H, Knuth A, van den Broek M.

Cancer Immunol Res. 2013 Nov;1(5):288-95. doi: 10.1158/2326-6066.CIR-13-0113. Epub 2013 Sep 25.

11.

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.

Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U, Zieschang J, Forssmann U, Woelfel T, Kaempgen E.

Cancer Immunol Immunother. 2014 Apr;63(4):381-94. doi: 10.1007/s00262-013-1516-5. Epub 2014 Feb 2.

PMID:
24487961
12.

Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.

Sah BR, Schibli R, Waibel R, von Boehmer L, Bläuenstein P, Nexo E, Johayem A, Fischer E, Müller E, Soyka JD, Knuth AK, Haerle SK, Schubiger PA, Schaefer NG, Burger IA.

J Nucl Med. 2014 Jan;55(1):43-9. doi: 10.2967/jnumed.113.122499. Epub 2013 Dec 12.

13.

NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.

von Boehmer L, Mattle M, Bode P, Landshammer A, Schäfer C, Nuber N, Ritter G, Old L, Moch H, Schäfer N, Jäger E, Knuth A, van den Broek M.

Cancer Immun. 2013 Jul 15;13:12. Print 2013.

14.

Radiotherapy of human sarcoma promotes an intratumoral immune effector signature.

Sharma A, Bode B, Studer G, Moch H, Okoniewski M, Knuth A, von Boehmer L, van den Broek M.

Clin Cancer Res. 2013 Sep 1;19(17):4843-53. doi: 10.1158/1078-0432.CCR-13-0352. Epub 2013 Jul 16.

15.

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.

Dannenmann SR, Thielicke J, Stöckli M, Matter C, von Boehmer L, Cecconi V, Hermanns T, Hefermehl L, Schraml P, Moch H, Knuth A, van den Broek M.

Oncoimmunology. 2013 Mar 1;2(3):e23562.

16.

MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients.

Nuber N, Curioni-Fontecedro A, Dannenmann SR, Matter C, von Boehmer L, Atanackovic D, Knuth A, van den Broek M.

Leukemia. 2013 Aug;27(8):1767-9. doi: 10.1038/leu.2013.31. Epub 2013 Feb 1. No abstract available.

PMID:
23429573
17.

A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.

Gupta A, Nuber N, Esslinger C, Wittenbrink M, Treder M, Landshammer A, Noguchi T, Kelly M, Gnjatic S, Ritter E, von Boehmer L, Nishikawa H, Shiku H, Old L, Ritter G, Knuth A, van den Broek M.

Cancer Immun. 2013;13:3. Epub 2013 Jan 15.

18.

Radiotherapy supports protective tumor-specific immunity.

Gupta A, Sharma A, von Boehmer L, Surace L, Knuth A, van den Broek M.

Oncoimmunology. 2012 Dec 1;1(9):1610-1611.

19.

New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models.

Lehmann K, Rickenbacher A, Jang JH, Oberkofler CE, Vonlanthen R, von Boehmer L, Humar B, Graf R, Gertsch P, Clavien PA.

Ann Surg. 2012 Nov;256(5):730-7; discussion 737-8. doi: 10.1097/SLA.0b013e3182737517.

PMID:
23095616
20.

Immunosuppression and lung cancer of donor origin after bilateral lung transplantation.

von Boehmer L, Draenert A, Jungraithmayr W, Inci I, Niklaus S, Boehler A, Hofer M, Stahel R, Soltermann A, van den Broek M, Weder W, Knuth A.

Lung Cancer. 2012 Apr;76(1):118-22. doi: 10.1016/j.lungcan.2011.10.001. Epub 2011 Nov 15.

PMID:
22088939
21.

MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer.

von Boehmer L, Keller L, Mortezavi A, Provenzano M, Sais G, Hermanns T, Sulser T, Jungbluth AA, Old LJ, Kristiansen G, van den Broek M, Moch H, Knuth A, Wild PJ.

PLoS One. 2011;6(7):e21366. doi: 10.1371/journal.pone.0021366. Epub 2011 Jul 6.

22.

Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients.

Karbach J, Neumann A, Atmaca A, Wahle C, Brand K, von Boehmer L, Knuth A, Bender A, Ritter G, Old LJ, Jäger E.

Clin Cancer Res. 2011 Feb 15;17(4):861-70. doi: 10.1158/1078-0432.CCR-10-1811. Epub 2010 Dec 16.

23.

Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.

Nuber N, Curioni-Fontecedro A, Matter C, Soldini D, Tiercy JM, von Boehmer L, Moch H, Dummer R, Knuth A, van den Broek M.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15187-92. doi: 10.1073/pnas.1002155107. Epub 2010 Aug 9.

24.

Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases.

Goetti R, Leschka S, Desbiolles L, Klotz E, Samaras P, von Boehmer L, Stenner F, Reiner C, Stolzmann P, Scheffel H, Knuth A, Marincek B, Alkadhi H.

Invest Radiol. 2010 Jul;45(7):419-26. doi: 10.1097/RLI.0b013e3181e1937b.

PMID:
20498611
25.

Developments in cancer immunotherapy.

van den Broek M, von Boehmer L, Knuth A.

Dig Dis. 2010;28(1):51-6. doi: 10.1159/000282064. Epub 2010 May 7. Review.

26.

Particle size and activation threshold: a new dimension of danger signaling.

Rettig L, Haen SP, Bittermann AG, von Boehmer L, Curioni A, Krämer SD, Knuth A, Pascolo S.

Blood. 2010 Jun 3;115(22):4533-41. doi: 10.1182/blood-2009-11-247817. Epub 2010 Mar 19.

27.

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.

Curioni-Fontecedro A, Knights AJ, Tinguely M, Nuber N, Schneider C, Thomson CW, von Boehmer L, Bossart W, Pahlich S, Gehring H, Moch H, Renner C, Knuth A, Zippelius A.

Leukemia. 2008 Aug;22(8):1646-8. doi: 10.1038/leu.2008.43. Epub 2008 Mar 6. No abstract available.

PMID:
18323799
28.

Images in cardiovascular medicine. Infarction-like electrocardiographic changes due to a myocardial metastasis from a primary lung cancer.

Samaras P, Stenner-Liewen F, Bauer S, Goerres GW, von Boehmer L, Kotrubczik N, Jenni R, Renner C, Knuth A.

Circulation. 2007 Mar 13;115(10):e320-1. No abstract available.

PMID:
17353451
29.

Alteration of GABAergic synapses and gephyrin clusters in the thalamic reticular nucleus of GABAA receptor alpha3 subunit-null mice.

Studer R, von Boehmer L, Haenggi T, Schweizer C, Benke D, Rudolph U, Fritschy JM.

Eur J Neurosci. 2006 Sep;24(5):1307-15.

PMID:
16987218
30.

A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.

Yee BK, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N, Dong Y, Malenka RC, Fritschy JM, Bluethmann H, Feldon J, Möhler H, Rudolph U.

Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17154-9. Epub 2005 Nov 11.

Supplemental Content

Loading ...
Support Center